Doctor profile · Federal record
Dr. ABDALLAH ALTARSHAN, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · Internal Medicine Physician · EVERGREEN PARK, IL
- NPI 1174582811
- Accepts Medicare
- 36 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
2955 W 95TH ST
EVERGREEN PARK, IL 608052409
(708) 422-0022 - Additional location
-
15300 West Ave Ste 122
Orland Park, IL 604624508
(708) 403-8400
fax (708) 403-8492
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- March 18, 2022
- Year of graduation
- 1990 — 36 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Illinois #036093254
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1174582811. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,233
Distinct HCPCS
10
Medicare allowed
$303,143
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 1,065 | 394 | $3 | |
83037 |
Hemoglobin a1c level, by device for home use | 1,021 | 389 | $9 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 956 | 202 | $83 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 806 | 419 | $94 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 515 | 232 | $133 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 305 | 124 | $36 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 209 | 186 | $137 | |
J3489 |
Injection, zoledronic acid, 1 mg | 108 | 24 | $9 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 73 | 73 | $175 | |
76536 |
Ultrasound scan of head and neck soft tissue | 56 | 54 | $117 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 328. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$11,884
Transactions
104
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 20 | $9,241.68 | |
| Insulet Corporation | 7 | $335.65 | |
| Lilly USA, LLC | 13 | $290.89 | |
| Corcept Therapeutics | 8 | $287.97 | |
| Abbott Laboratories | 6 | $233.99 | |
| Xeris Pharmaceuticals, Inc. | 9 | $192.96 | |
| Ascensia Diabetes Care Us Inc. | 5 | $179.07 | |
| Mannkind Corporation | 8 | $167.56 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $154.21 | |
| AstraZeneca Pharmaceuticals LP | 9 | $131.52 | |
| Dexcom, Inc. | 1 | $115.54 | |
| Ultragenyx Pharmaceutical Inc. | 4 | $88.95 | |
| Amgen Inc. | 4 | $82.84 | |
| ABBVIE INC. | 3 | $58.91 | |
| SANOFI-AVENTIS U.S. LLC | 2 | $50.04 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,728
Patients
1,192
Total drug cost
$3,550,978
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 831 | 178 | $1,226,223 |
| Metformin Hcl | Generic | 663 | 176 | $7,222 |
| Jardiance (Empagliflozin) | Brand | 407 | 85 | $417,799 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 335 | 91 | $256,314 |
| Glipizide | Generic | 296 | 78 | $3,656 |
| Levothyroxine Sodium | Generic | 284 | 86 | $5,538 |
| Humalog Kwikpen U-100 (Insulin Lispro) | Brand | 257 | 71 | $290,122 |
| Trulicity (Dulaglutide) | Brand | 251 | 44 | $319,633 |
| Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 230 | 91 | $22,430 |
| Omnipod Dash Pods (Gen 4) (Insulin Pump Cart,cont Inf,bt) | Brand | 213 | 39 | $272,205 |